文献速递免疫规划妇幼与学校卫生

妊娠期百日咳疫苗接种与绒毛膜羊膜炎及不良妊娠结局的系统综述与荟萃分析

Systematic review and meta-analysis of the effect of pertussis vaccine in pregnancy on the risk of chorioamnionitis, non-pertussis infectious diseases and other adverse pregnancy outcomes.
PubMed 文献 · Vaccine · 2021-02-25

该系统综述与荟萃分析检索PubMed和Embase至2021年1月14日,纳入13项观察性研究和6项随机对照试验,评估妊娠期百日咳疫苗接种对绒毛膜羊膜炎、非百日咳感染及其他不良妊娠结局的影响。汇总6项观察性研究显示,接种组绒毛膜羊膜炎风险升高(RR=1.27,95%CI 1.14-1.42),次要结局未见差异。结论提示需进一步随机试验评估孕期含百日咳成分疫苗的潜在不良反应。

要点

  • 孕期接种百日咳疫苗与绒毛膜羊膜炎风险升高相关(RR=1.27,95%CI 1.14-1.42)。
  • 非百日咳感染、自然流产或死胎、死亡等次要结局未见差异。
  • 需进一步随机试验评估孕期含百日咳成分疫苗的潜在不良反应。

核心结论

  • 孕期接种百日咳疫苗的女性绒毛膜羊膜炎风险升高,RR=1.27(95%CI 1.14-1.42)。
  • 次要结局包括非百日咳感染、自然流产或死胎及死亡,分析未见差异。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed和Embase至2021年1月14日。
  • 纳入13项观察性研究和6项随机对照试验,按研究类型分层进行荟萃分析。

主要发现

  • 汇总6项观察性研究数据,孕期接种百日咳疫苗(多与其他非活疫苗接种比较)与绒毛膜羊膜炎风险升高相关,RR=1.27(95%CI 1.14-1.42)。
  • 次要结局非百日咳感染、自然流产或死胎及死亡的分析未见差异。

临床怎么用

  • 孕期接种百日咳疫苗时需关注绒毛膜羊膜炎风险信号,但目前证据主要来自观察性研究。

局限性

  • 原文未明确报告纳入研究的偏倚风险具体结果及异质性指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Several countries have introduced maternal immunisation with pertussis vaccine to provide protection against pertussis in early infancy. There is increasing interest in non-specific effects of vaccines including that non-live vaccines may enhance susceptibility to non-targeted infections in females. Some studies have shown increased risk of chorioamnionitis among women receiving pertussis vaccine during pregnancy. We aimed to conduct a systematic review and meta-analysis of the effect of maternal pertussis immunisation on the risk of chorioamnionitis, as well as the secondary outcomes of non-pertussis infections in women, non-pertussis infections in infants, spontaneous abortion or stillbirth, maternal death and infant death. METHODS: We searched PubMed and Embase for articles published until January 14, 2021. We screened articles for eligibility and extracted data using Covidence. Quality was assessed using Cochrane RoB tool and Newcastle-Ottawa Scale. Data were imported into RevMan for pooling and conduction of a meta-analysis stratified by study type. Outcomes are presented as risk ratios. RESULTS: We identified 13 observational studies and six randomized controlled trials eligible for inclusion. We pooled data on chorioamnionitis from six observational studies and found maternal pertussis vaccine (mostly compared with other maternal immunizations with non-live vaccines) to be associated with an increased risk among the pertussis vaccinated women, RR = 1.27 [CI 95%: 1.14-1.42]. We found no difference in the analysis of our secondary outcomes of non-pertussis infections, spontaneous abortion or stillbirth and death. CONCLUSION: We found an increased risk of chorioamnionitis among women who received pertussis vaccine in pregnancy. The large number of women receiving pertussis vaccine during pregnancy, as well as the growing evidence of non-live vaccines causing increased susceptibility to infections, indicates a need for further randomised trials to assess potential adverse effects of maternal immunisation with pertussis-containing vaccines.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Andersen AR, Kolmos SK, Flanagan KL, et al. Systematic review and meta-analysis of the effect of pertussis vaccine in pregnancy on the risk of chorioamnionitis, non-pertussis infectious diseases and other adverse pregnancy outcomes. Vaccine. 2021. PMID: 33642162. doi:10.1016/j.vaccine.2021.02.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。